VIVEK SUBBIAH to Class I Phosphatidylinositol 3-Kinases
This is a "connection" page, showing publications VIVEK SUBBIAH has written about Class I Phosphatidylinositol 3-Kinases.
Connection Strength
0.105
-
The emerging role of PI3K inhibitors for solid tumour treatment and beyond. Br J Cancer. 2023 06; 128(12):2150-2162.
Score: 0.048
-
Comprehensive genomic profiling of 295 cases of clinically advanced urothelial carcinoma of the urinary bladder reveals a high frequency of clinically relevant genomic alterations. Cancer. 2016 Mar 01; 122(5):702-11.
Score: 0.029
-
Hotspot mutation panel testing reveals clonal evolution in a study of 265 paired primary and metastatic tumors. Clin Cancer Res. 2015 Jun 01; 21(11):2644-51.
Score: 0.028